Freeline Reports Half Year 2020 Financial Results and Recent Business Highlights

NEXT STORY
Resuscitation Devices Market Was Worth US$ 6.2 Billion in 2019 and is Expected to Reach US$ 10.3 Billion at a CAGR of 4.9%
PREV STORY
Equillium Receives FDA Clearance of COVID-19 IND for Phase 3 Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance

author_avatar
NASDAQ Market News

Viridian Therapeutics Announces First Subject Dosed in Phase 1/2 Clinical Trial of VRDN-001 for Thyroid Eye Disease (TED)

author_avatar
NASDAQ Market News

FDA approves Roche’s Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment

author_avatar
NASDAQ Market News